We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

74 hedge funds and large institutions have $293M invested in Avadel Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

150% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 12

78% more call options, than puts

Call options by funds: $7.34M | Put options by funds: $4.11M

39% more capital invested

Capital invested by funds: $211M → $293M (+$81.9M)

32% more funds holding

Funds holding: 56 → 74 (+18)

9.18% less ownership

Funds ownership: 71.59% → 62.4% (-9.2%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
74
Holders Change
+18
Holders Change %
+32.14%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
30
Increased
27
Reduced
10
Closed
12
Calls
$7.34M
Puts
$4.11M
Net Calls
+$3.23M
Net Calls Change
-$22.7M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$27.6M
2
PC
Polar Capital
United Kingdom
+$26.3M
3
RI
RTW Investments
New York
+$6.08M
4
JGC
J. Goldman & Co
New York
+$5.71M
5
ACM
Asymmetry Capital Management
California
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$8.12M
2
DCM
Driehaus Capital Management
Illinois
-$3.9M
3
TCM
Tekla Capital Management
Massachusetts
-$2.93M
4
Goldman Sachs
Goldman Sachs
New York
-$1.52M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.16M -$200K -22,672 -14%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$1.06M +$476K +54,017 +70%
Calamos Advisors
28
Calamos Advisors
Illinois
$862K +$941K +106,776 New
MCM
29
Moore Capital Management
New York
$808K +$882K +100,000 New
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$789K +$861K +97,687 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$779K +$850K +96,414 New
CS
32
Candriam SCA
Luxembourg
$687K +$749K +85,000 New
KP
33
Keel Point
Alabama
$584K +$13.7K +1,551 +2%
GCM
34
Graham Capital Management
Connecticut
$513K +$561K +63,600 New
Russell Investments Group
35
Russell Investments Group
United Kingdom
$499K +$546K +61,986 New
SSA
36
Schonfeld Strategic Advisors
New York
$463K +$505K +57,300 New
BFM
37
Boothbay Fund Management
New York
$417K +$454K +51,550 New
HS
38
HighVista Strategies
Massachusetts
$415K +$453K +51,408 New
Citadel Advisors
39
Citadel Advisors
Florida
$404K +$271K +30,759 +160%
DTL
40
Dynamic Technology Lab
Singapore
$355K +$387K +43,919 New
Barclays
41
Barclays
United Kingdom
$328K +$234K +26,566 +189%
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
$309K +$239K +27,133 +245%
IAMOG
43
Investors Asset Management of Georgia
Georgia
$292K +$31.7K +3,600 +11%
VF
44
Virtu Financial
New York
$267K +$291K +33,048 New
EVM
45
Eaton Vance Management
Massachusetts
$260K – – –
Geode Capital Management
46
Geode Capital Management
Massachusetts
$221K +$11.3K +1,282 +5%
QSS
47
Quantitative Systematic Strategies
Florida
$220K +$240K +27,196 New
OC
48
Oppenheimer & Co
New York
$184K +$201K +22,814 New
Northern Trust
49
Northern Trust
Illinois
$175K +$59.5K +6,744 +45%
EGM
50
Engineers Gate Manager
New York
$171K +$187K +21,200 New
1
2
3 4

AVDL Hedge Fund Activity: Q2 2020 in Review

74 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2020, worth a combined $293M — up 39% from $211M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AVDL positions and 12 closed out — a net gain of 18 holders — while 27 added to existing stakes and 10 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $27.6M. The largest seller was Acuta Capital Partners, cutting an estimated $8.12M.

  • 74 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2020, up from 56 in Q1 2020.
  • Funds reported $293M of Avadel Pharmaceuticals stock for Q2 2020, up 39% quarter-over-quarter.
  • 30 funds opened new Avadel Pharmaceuticals positions in Q2 2020 and 12 closed out, a net change of +18 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2020 was RA Capital Management, an estimated $27.6M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2020 was Acuta Capital Partners, an estimated $8.12M sold.

Based on aggregated 13F filings for Q2 2020.